Published in
Elsevier, Journal of Heart and Lung Transplantation, 4(37), p. S90-S91
DOI: 10.1016/j.healun.2018.01.211
Elsevier, International Journal of Cardiology, (265), p. 71-76, 2018
DOI: 10.1016/j.ijcard.2018.03.111
Links
Tools
Outcomes associated with mammalian target of rapamycin (mTOR) inhibitors in heart transplant recipients: A meta-analysis
Journal article published in 2018 by
Nicholas Lange 
,
Douglas L. Jennings,
Michael Shullo,
Farhana Latif,
Susan Restaino,
Veli K. Topkara,
Koji Takeda,
Hiroo Takayama,
Yoshifumi Naka,
Maryjane Farr,
William L. Baker,
Paolo Colombo
,
Douglas L. Jennings,
Michael Shullo,
Farhana Latif,
Susan Restaino,
Veli K. Topkara,
Koji Takeda,
Hiroo Takayama,
Yoshifumi Naka,
Maryjane Farr,
William L. Baker,
Paolo Colombo
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Postprint:
archiving forbidden
Published version:
archiving forbidden
Data provided by 